Preconditioning and postconditioning: united at reperfusion.

Area of Science:

• Cardiovascular Medicine
• Molecular Cardiology
• Pharmacology

Background:

• Coronary heart disease (CHD) remains a leading cause of death globally, necessitating novel cardioprotective therapies.
• Ischemic preconditioning (IPC) and ischemic postconditioning (IPost) offer cardioprotection via transient ischemia/reperfusion protocols.
• Understanding the shared signaling mechanisms is key to developing new treatments.

Purpose of the Study:

• To review the common signaling pathway underlying both IPC and IPost cardioprotection.
• To highlight the critical role of early reperfusion minutes in these protective effects.
• To explore the clinical potential of targeting this pathway for CHD treatment.

Main Methods:

• Review of existing literature on IPC and IPost signaling.
• Analysis of the reperfusion injury salvage kinase (RISK) pathway, redox signaling, and mitochondrial permeability transition pore (mPTP).
• Identification of common molecular targets activated during myocardial reperfusion.

Main Results:

• IPC and IPost recruit a similar signaling cascade during myocardial reperfusion.
• This shared pathway involves cell-surface receptors, protein kinases (e.g., RISK pathway), redox signaling, and the mPTP.
• The initial minutes of reperfusion are critical for initiating cardioprotection.

Conclusions:

• A common cardioprotective signaling pathway unites IPC and IPost.
• Pharmacological activation of this pathway during reperfusion is feasible in a clinical setting.
• Targeting these signaling components offers a promising strategy for novel CHD treatments.